Jeffrey Allen

Summary

Affiliation: New York University School of Medicine
Country: USA

Publications

  1. pmc Diagnostic sensitivity of serum and lumbar CSF bHCG in newly diagnosed CNS germinoma
    Jeffrey Allen
    NYU Langone Medical Center, New York, NY 10016, USA
    Pediatr Blood Cancer 59:1180-2. 2012
  2. pmc A phase II study of preradiotherapy chemotherapy followed by hyperfractionated radiotherapy for newly diagnosed high-risk medulloblastoma/primitive neuroectodermal tumor: a report from the Children's Oncology Group (CCG 9931)
    Jeffrey Allen
    Departments of Pediatrics and Pathology, New York University Medical Center, New York, NY 10016, USA
    Int J Radiat Oncol Biol Phys 74:1006-11. 2009
  3. ncbi request reprint Brainstem primitive neuroectodermal tumors (bstPNET): results of treatment with intensive induction chemotherapy followed by consolidative chemotherapy with autologous hematopoietic cell rescue
    Jason R Fangusaro
    The Children s Hospital Los Angeles, New York University Medical Center, Memorial Sloan Kettering Cancer Center, and Schneider Children s Hospital, USA
    Pediatr Blood Cancer 50:715-7. 2008
  4. doi request reprint Prospective neuraxis MRI surveillance reveals a high risk of leptomeningeal dissemination in diffuse intrinsic pontine glioma
    Rajni Sethi
    Department of Radiation Oncology, New York University Langone Medical Center, 566 First Avenue, New York, NY 10014, USA
    J Neurooncol 102:121-7. 2011
  5. pmc Bevacizumab in recurrent high-grade pediatric gliomas
    Ashwatha Narayana
    Department of Radiation Oncology, New York University Langone Medical Center, New York, New York 10016, USA
    Neuro Oncol 12:985-90. 2010
  6. pmc Long-term follow-up of children treated for high-grade gliomas: children's oncology group L991 final study report
    Stephen Alan Sands
    Columbia University College of Physicians and Surgeons, New York, NY, USA
    J Clin Oncol 30:943-9. 2012

Detail Information

Publications6

  1. pmc Diagnostic sensitivity of serum and lumbar CSF bHCG in newly diagnosed CNS germinoma
    Jeffrey Allen
    NYU Langone Medical Center, New York, NY 10016, USA
    Pediatr Blood Cancer 59:1180-2. 2012
    ..There is less information on the diagnostic sensitivity of bHCG assays in germinoma...
  2. pmc A phase II study of preradiotherapy chemotherapy followed by hyperfractionated radiotherapy for newly diagnosed high-risk medulloblastoma/primitive neuroectodermal tumor: a report from the Children's Oncology Group (CCG 9931)
    Jeffrey Allen
    Departments of Pediatrics and Pathology, New York University Medical Center, New York, NY 10016, USA
    Int J Radiat Oncol Biol Phys 74:1006-11. 2009
    ....
  3. ncbi request reprint Brainstem primitive neuroectodermal tumors (bstPNET): results of treatment with intensive induction chemotherapy followed by consolidative chemotherapy with autologous hematopoietic cell rescue
    Jason R Fangusaro
    The Children s Hospital Los Angeles, New York University Medical Center, Memorial Sloan Kettering Cancer Center, and Schneider Children s Hospital, USA
    Pediatr Blood Cancer 50:715-7. 2008
    ..Two patients survive at least 32 months with stable disease. This approach provides an alternative for young patients with bstPNET who in prior reports have had a uniformly fatal prognosis...
  4. doi request reprint Prospective neuraxis MRI surveillance reveals a high risk of leptomeningeal dissemination in diffuse intrinsic pontine glioma
    Rajni Sethi
    Department of Radiation Oncology, New York University Langone Medical Center, 566 First Avenue, New York, NY 10014, USA
    J Neurooncol 102:121-7. 2011
    ..All patients should undergo routine craniospinal imaging at diagnosis and follow-up. Central nervous system prophylaxis should be considered in future clinical trials...
  5. pmc Bevacizumab in recurrent high-grade pediatric gliomas
    Ashwatha Narayana
    Department of Radiation Oncology, New York University Langone Medical Center, New York, New York 10016, USA
    Neuro Oncol 12:985-90. 2010
    ..However, the radiological response rate, response duration, and survival appeared inferior in pediatric patients. Genetic differences in pediatric gliomas might account for this difference...
  6. pmc Long-term follow-up of children treated for high-grade gliomas: children's oncology group L991 final study report
    Stephen Alan Sands
    Columbia University College of Physicians and Surgeons, New York, NY, USA
    J Clin Oncol 30:943-9. 2012
    ..The Children's Oncology Group (COG) L991 study investigated the neuropsychological, behavioral, and quality of life (QoL) outcomes after treatment on the Children's Cancer Group (CCG) trial for high-grade gliomas (CCG-945)...